Floatz logo

Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Prourokinase
Ischemic Stroke
General Hospital of Shenyang Military RegionP3B (63)
Pumitamig
Non-Small Cell Lung Carcinoma
M.D. Anderson Cancer CenterP3B (63)
Rap-219
Focal Epilepsy
Rapport Therapeutics Inc.P3B (63)
Realgar-Indigo Naturalis Formulation
Acute Promyelocytic Leukemia
Instituto do Cancer do Estado de São PauloP3B (63)
Rph-075
Cutaneous Melanoma
R-PharmP3B (63)
S-1
Colorectal Cancer
Tao ZhangP3B (63)
Saroglitazar
Primary Biliary Cholangitis
Zydus Therapeutics Inc.P3B (63)
sb27
Non-Small Cell Lung Carcinoma
Samsung Bioepis Co., Ltd.P3B (63)
Sonlicromanol
Maternally-Inherited Diabetes And Deafness
Khondrion BVP3B (63)
Soticlestat
Dravet Syndrome
TakedaP3B (63)
Soticlestat
Lennox-Gastaut Syndrome
TakedaP3B (63)
Sugemalimab
Non-Small Cell Lung Carcinoma
Shanghai Pulmonary Hospital, Shanghai, ChinaP3B (63)
Tarlatamab
Small Cell Lung Carcinoma
PrECOG, LLC.P3B (63)
Tenofovir
Hepatocellular Carcinoma
Zhongshan Hospital (Xiamen), Fudan UniversityP3B (63)
Trastuzumab Emtansine
Inflammatory Breast Carcinoma
Hoffmann-La RocheP3B (63)
Tucatinib
Breast Carcinoma
Dana-Farber Cancer InstituteP3B (63)
Tuvonralimab
Small Cell Lung Carcinoma
The Second Affiliated Hospital of Dalian Medical UniversityP3B (63)
Vatiquinone
Friedreich Ataxia
PTC TherapeuticsP3B (63)
Volitinib
Renal Cell Carcinoma
AstraZenecaP3B (63)
Xcopri
Focal Epilepsy
SK Life Science, Inc.P3B (63)
xnw5004
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Evopoint Biosciences Inc.P3B (63)
Zanidatamab
HER2 Positive Breast Carcinoma
MedSIRP3B (63)
Adebrelimab
Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP3B (62)
Alpha Tocopherol
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hawler Medical UniversityP3B (62)
Apalutamide
Castration-Resistant Prostate Carcinoma
Mayo ClinicP3B (62)
Showing 2401 to 2425 of 5,098 assets
PreviousPage 97 of 204Next